HMGA1 Modulates Gene Transcription Sustaining a Tumor Signalling Pathway Acting on the Epigenetic Status of Triple-Negative Breast Cancer Cells (original) (raw)

HMGA1 overexpression is associated with a particular subset of human breast carcinomas

Salvatore Piscuoglio

Journal of Clinical Pathology, 2015

View PDFchevron_right

HMGA proteins as modulators of chromatin structure during transcriptional activation

Dr. Indrabahadur Singh

Frontiers in Cell and Developmental Biology, 2014

View PDFchevron_right

Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer

Ingrid Hedenfalk

Modern Pathology, 2014

View PDFchevron_right

HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells

Saraswati Sukumar

PLoS ONE, 2013

View PDFchevron_right

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients

Carsten Rose

BMC Clinical Pathology, 2015

View PDFchevron_right

HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer

Henrik Ditzel

Cancers, 2021

View PDFchevron_right

Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategies

Gloria Ros

Expert Opinion on Therapeutic Targets, 2020

View PDFchevron_right

hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment

A. Zaravinos

Int. J. Biol. Markers, 2012

View PDFchevron_right

HMGA2 as a Critical Regulator in Cancer Development

Henrik Ditzel

Genes, 2021

View PDFchevron_right

High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer

Alessandro Ottaiano

Journal of Cellular Physiology, 2013

View PDFchevron_right

HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis

Miao Sun

Proceedings of the National Academy of Sciences, 2013

View PDFchevron_right

The HLA class III subregion is responsible for an increased breast cancer risk

Jan Kleibeuker

Human Molecular Genetics, 2003

View PDFchevron_right

HMGA1 protein expression in familial breast carcinoma patients

Gennaro Chiappetta

European Journal of Cancer, 2010

View PDFchevron_right

Heterochromatin Protein 1γ Epigenetically Regulates Cell Differentiation and Exhibits Potential as a Therapeutic Target for Various Types of Cancers

Masakatsu Takanashi

American Journal of Pathology, 2009

View PDFchevron_right

HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!

Josep Villanueva

Biomolecules

View PDFchevron_right

The double life of HMGB1 chromatin protein: Architectural factor and extracellular signal

Tiziana Bonaldi

EMBO Journal, 2001

View PDFchevron_right

Clinical Implications of Extracellular HMGA1 in Breast Cancer

Josep Villanueva

International Journal of Molecular Sciences, 2019

View PDFchevron_right

HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway

Maria Nevolo

Scientific Reports, 2012

View PDFchevron_right

In vivo expression of the whole HOX gene network in human breast cancer

Isidoro Feliciello

European Journal of Cancer, 2003

View PDFchevron_right

HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT

Roberta Sommaggio

2016

View PDFchevron_right

Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer

John Martens

Radiotherapy and Oncology, 2011

View PDFchevron_right

Hypoxia inducible factor-1α (HIF-1α) and matrix metalloproteinase 9 (MMP-9) expression in invasive breast cancer

Michalis Leotsinidis

2016

View PDFchevron_right

Gene expression in inherited breast cancer

Ingrid Hedenfalk

Advances in Cancer Research, 2002

View PDFchevron_right

HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel

Gloria Ros

Cell Death and Disease, 2022

View PDFchevron_right

HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells

Alessandra Zicari

Oncology Reports, 2012

View PDFchevron_right

HOX gene methylation status analysis in patients with hereditary breast cancer

Simona De Summa

Journal of Human Genetics, 2013

View PDFchevron_right

HMGA1 Protein Overexpression in Human Breast Carcinomas: Correlation with ErbB2 Expression

Vincenzo Giancotti

Clinical Cancer Research, 2004

View PDFchevron_right

HMGA2 Participates in Transformation in Human Lung Cancer

Linda Resar

Molecular Cancer Research, 2008

View PDFchevron_right

Breast Cancer from Molecular Point of View: Pathogenesis and Biomarkers

Maliheh Parsa

Breast Cancer - Focusing Tumor Microenvironment, Stem cells and Metastasis, 2011

View PDFchevron_right

The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development

Lionel Chia

Current Molecular Medicine, 2016

View PDFchevron_right

Protein expression patterns of cell cycle regulators in operable breast cancer

HELEN TRIHIA, E. Samantas

PLOS ONE, 2017

View PDFchevron_right

Prognostic Significance of HMGA1 Expression in Lung Cancer Based on Bioinformatics Analysis

Marek Mirowski

International Journal of Molecular Sciences

View PDFchevron_right

The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer

Michele Balsamo, Paola Trono

Plos One, 2010

View PDFchevron_right

Proteins Involved in HDACi Induced Decay of ERBB2 Transcripts in Breast Cancer

Sadaf Malik

View PDFchevron_right